Search

everythinglearnresearchcommunity

for

Search:↓

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

CD80 on skin stem cells helps expand Treg cells to aid wound healing.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Thymoma with alopecia areata may be linked to abnormal immune cells.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

UV light helped human hair transplants survive in mice without broad immunosuppression.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Targeting Keratin 17 may help overcome cancer therapy resistance.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

CD4 is crucial for maintaining skin stem cell balance and aiding wound healing.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.